Monopar Therapeutics Inc. (MNPR) SEC filings
MNPR SEC filings moved a median of -2.53% by the close. MNPR SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the MNPR overview →
82 measured MNPR SEC filing events.
Where these MNPR SEC filings landedvs 77 measured MNPR SEC filing reactions
| Middle 50% of MNPR SEC filing reactions | -5.41% to +1.92% |
|---|---|
| Median reaction (to close) | -2.53% |
| Measured reactions | 77 |
Point-in-time · zero look-ahead
Half of the 77 MNPR SEC filing events with a measured close landed between -5.41% and +1.92%; 32% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Monopar Therapeutics For: Jun 30 | SEC filing · Form 10-Q | +0.21% | -0.25% | |
| Form 8-K Monopar Therapeutics For: Aug 12 | SEC filing · Form 8-K | +0.18% | -0.25% | |
| Form 8-K Monopar Therapeutics For: Jul 22 | SEC filing · Form 8-K | +0.00% | -0.49% | |
| Form S-8 Monopar Therapeutics | SEC filing · Form S-8 | -3.41% | -4.66% | |
| Form S-8 POS Monopar Therapeutics | SEC filing · Form S-8 | -3.41% | -4.66% | |
| Form 8-K Monopar Therapeutics For: Jun 30 | SEC filing · Form 8-K | -0.28% | -3.96% | |
| Form 8-K Monopar Therapeutics For: Jun 26 | SEC filing · Form 8-K | -0.26% | +7.85% | |
| Form 8-K Monopar Therapeutics For: Jun 22 | SEC filing · Form 8-K | +2.88% | +19.88% | |
| Form 8-K Monopar Therapeutics For: May 29 | SEC filing · Form 8-K | -0.96% | -0.37% | |
| Form 8-K Monopar Therapeutics For: May 19 | SEC filing · Form 8-K | -1.38% | +16.44% | |
| Form 10-Q Monopar Therapeutics For: Mar 31 | SEC filing · Form 10-Q | +1.60% | +1.62% | |
| Form 8-K Monopar Therapeutics For: May 14 | SEC filing · Form 8-K | -0.10% | +0.74% | |
| Form ARS Monopar Therapeutics For: Dec 31 | SEC filing · Form ARS | -2.15% | +2.19% | |
| Form DEF 14A Monopar Therapeutics For: Jun 22 | SEC filing · Form DEF | -2.15% | +2.19% | |
| Form DEFA14A Monopar Therapeutics | SEC filing · Form DEFA14A | -2.15% | +2.19% | |
| Form 8-K Monopar Therapeutics For: Apr 19 | SEC filing · Form 8-K | -0.39% | -2.70% | |
| Form 10-K/A Monopar Therapeutics For: Dec 31 | SEC filing · Form 10-K | +0.10% | -4.10% | |
| Form 10-K Monopar Therapeutics For: Dec 31 | SEC filing · Form 10-K | -0.83% | -2.82% | |
| Form 8-K Monopar Therapeutics For: Mar 27 | SEC filing · Form 8-K | -1.41% | -3.29% | |
| Form 8-K Monopar Therapeutics For: Mar 02 | SEC filing · Form 8-K | +1.99% | +0.38% | |
| Form 10-Q Monopar Therapeutics For: Sep 30 | SEC filing · Form 10-Q | +0.43% | — | |
| Form 8-K Monopar Therapeutics For: Nov 13 | SEC filing · Form 8-K | +0.43% | — | |
| Form 8-K Monopar Therapeutics For: Nov 09 | SEC filing · Form 8-K | -2.78% | -2.68% | |
| Form 8-K Monopar Therapeutics For: Sep 23 | SEC filing · Form 8-K | -1.84% | +3.42% | |
| Form 8-K Monopar Therapeutics For: Sep 15 | SEC filing · Form 8-K | +0.02% | +4.95% | |
| Form EFFECT Monopar Therapeutics | SEC filing · Form EFFECT | +0.00% | -1.51% | |
| Form S-3 Monopar Therapeutics | SEC filing · Form S-3 | — | +1.53% | |
| Form 10-Q Monopar Therapeutics For: Jun 30 | SEC filing · Form 10-Q | — | — | |
| Form 8-K Monopar Therapeutics For: Aug 12 | SEC filing · Form 8-K | — | — | |
| Form 8-K Monopar Therapeutics For: Jun 17 | SEC filing · Form 8-K | +0.00% | -5.41% | |
| Form DEFA14A Monopar Therapeutics | SEC filing · Form DEFA14A | +0.20% | -0.15% | |
| Form 10-Q Monopar Therapeutics For: Mar 31 | SEC filing · Form 10-Q | +0.89% | -3.65% | |
| Form 8-K Monopar Therapeutics For: May 13 | SEC filing · Form 8-K | +0.89% | -3.65% | |
| Form ARS Monopar Therapeutics For: Dec 31 | SEC filing · Form ARS | +1.31% | -11.54% | |
| Form 8-K Monopar Therapeutics For: May 07 | SEC filing · Form 8-K | +0.00% | -3.93% | |
| Form DEF 14A Monopar Therapeutics For: Jun 17 | SEC filing · Form DEF | — | +1.38% | |
| Form 10-K Monopar Therapeutics For: Dec 31 | SEC filing · Form 10-K | +0.00% | -5.97% | |
| Form 8-K Monopar Therapeutics For: Mar 31 | SEC filing · Form 8-K | +0.00% | -5.97% | |
| Form S-8 Monopar Therapeutics | SEC filing · Form S-8 | +0.00% | -5.97% | |
| Form 8-K Monopar Therapeutics For: Feb 27 | SEC filing · Form 8-K | -2.49% | +3.76% | |
| Form 8-K Monopar Therapeutics For: Feb 19 | SEC filing · Form 8-K | -3.74% | -11.11% | |
| Form EFFECT Monopar Therapeutics | SEC filing · Form EFFECT | -0.86% | +20.17% | |
| Form S-3 Monopar Therapeutics | SEC filing · Form S-3 | -1.25% | +14.67% | |
| Form 8-K Monopar Therapeutics For: Dec 20 | SEC filing · Form 8-K | +1.27% | -6.96% | |
| Form EFFECT Monopar Therapeutics | SEC filing · Form EFFECT | +0.00% | -2.41% | |
| Form 8-K Monopar Therapeutics For: Dec 06 | SEC filing · Form 8-K | -2.02% | -7.61% | |
| Form S-3 Monopar Therapeutics | SEC filing · Form S-3 | +0.90% | -1.30% | |
| Form 10-Q Monopar Therapeutics For: Sep 30 | SEC filing · Form 10-Q | +2.44% | +2.93% | |
| Form 8-K Monopar Therapeutics For: Nov 08 | SEC filing · Form 8-K | +2.44% | +2.93% | |
| Form 8-K Monopar Therapeutics For: Oct 28 | SEC filing · Form 8-K | +0.14% | -1.89% | |
| Form 8-K Monopar Therapeutics For: Oct 23 | SEC filing · Form 8-K | -4.88% | — | |
| Form 8-K Monopar Therapeutics For: Oct 22 | SEC filing · Form 8-K | -5.46% | -4.54% | |
| Form 8-K Monopar Therapeutics For: Oct 15 | SEC filing · Form 8-K | +0.00% | -4.81% | |
| Form 8-K Monopar Therapeutics For: Oct 07 | SEC filing · Form 8-K | +3.63% | +12.39% | |
| Form 8-K Monopar Therapeutics For: Sep 12 | SEC filing · Form 8-K | -10.45% | -23.60% | |
| Form 8-K Monopar Therapeutics For: Aug 27 | SEC filing · Form 8-K | -1.25% | -5.83% | |
| Form 8-K Monopar Therapeutics For: Aug 21 | SEC filing · Form 8-K | -1.28% | +9.79% | |
| Form 8-K Monopar Therapeutics For: Aug 14 | SEC filing · Form 8-K | +0.00% | -14.61% | |
| Form 10-Q Monopar Therapeutics For: Jun 30 | SEC filing · Form 10-Q | -3.25% | -7.94% | |
| Form 8-K Monopar Therapeutics For: Aug 09 | SEC filing · Form 8-K | -3.25% | -7.94% | |
| Form ARS Monopar Therapeutics For: Dec 31 | SEC filing · Form ARS | +0.00% | -6.86% | |
| Form DEF 14A Monopar Therapeutics For: Aug 05 | SEC filing · Form DEF | +0.00% | -6.86% | |
| Form PRE 14A Monopar Therapeutics For: Aug 05 | SEC filing · Form PRE | -0.01% | -2.31% | |
| Form 8-K Monopar Therapeutics For: Jul 09 | SEC filing · Form 8-K | -3.24% | -4.87% | |
| Form 8-K Monopar Therapeutics For: Jun 11 | SEC filing · Form 8-K | +3.11% | +7.04% | |
| Form 8-K Monopar Therapeutics For: Jun 10 | SEC filing · Form 8-K | +1.22% | -7.65% | |
| Form 8-K Monopar Therapeutics For: May 23 | SEC filing · Form 8-K | -0.12% | +4.63% | |
| Form 10-Q Monopar Therapeutics For: Mar 31 | SEC filing · Form 10-Q | -3.85% | -8.83% | |
| Form 8-K Monopar Therapeutics For: May 09 | SEC filing · Form 8-K | -3.85% | -8.83% | |
| Form 8-K Monopar Therapeutics For: Apr 16 | SEC filing · Form 8-K | -2.19% | -0.27% | |
| Form 8-K Monopar Therapeutics For: Apr 10 | SEC filing · Form 8-K | +5.37% | +5.13% | |
| Form 10-K Monopar Therapeutics For: Dec 31 | SEC filing · Form 10-K | +0.00% | -2.85% | |
| Form 8-K Monopar Therapeutics For: Mar 28 | SEC filing · Form 8-K | +0.00% | -2.85% | |
| Form 8-K Monopar Therapeutics For: Mar 07 | SEC filing · Form 8-K | +6.15% | -1.03% | |
| Form 8-K Monopar Therapeutics For: Mar 05 | SEC filing · Form 8-K | +11.54% | +1.92% | |
| Form 8-K Monopar Therapeutics For: Feb 27 | SEC filing · Form 8-K | -0.04% | -2.91% | |
| Form 8-K Monopar Therapeutics For: Feb 27 | SEC filing · Form 8-K | -3.33% | -2.42% | |
| Form 8-K Monopar Therapeutics For: Feb 22 | SEC filing · Form 8-K | +0.07% | +43.55% | |
| Form 8-K Monopar Therapeutics For: Feb 20 | SEC filing · Form 8-K | +10.64% | -52.55% | |
| Form 10-Q Monopar Therapeutics For: Sep 30 | SEC filing · Form 10-Q | +0.00% | -2.53% | |
| Form 8-K Monopar Therapeutics For: Nov 09 | SEC filing · Form 8-K | +0.00% | -2.53% | |
| Form 8-K Monopar Therapeutics For: Nov 01 | SEC filing · Form 8-K | -6.19% | -18.16% |
Keep exploring
More MNPR: earnings → · analyst actions → · MNPR overview →